leisure time -WSS

leisure time

author：hotspot 2025-08-04 08:20:47 - browse：547

What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

hotspot

WSS

NYU Langone launches private ChatGPT for its health care data

After sickle

Why sickle cell disease is getting the first CRISPR treatment

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Complete sequence of Y chromosome published for first time

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

hotspot

leisure time

leisure time

23andMe had bad news about my health. I wish a person had delivered it

Spinal cord stimulation reduces pain in amputees, study finds

ChatGPT in medicine: STAT answers readers' burning questions

Feds fine Medicare Advantage plans for overcharging members

In Memoriam: Notable people who died in 2023

NYU Langone launches private ChatGPT for its health care data

BioMarin wins approval for gene therapy to treat hemophilia A

Supreme Court wrestles with OxyContin maker's bankruptcy deal

How one medical school became remarkably diverse

How Long Island became the ‘eugenics capital of the world’

entertainment

Psilocybin's anti

Radiation, mainstay of cancer treatment, begins a fade

Patients' immediate access to test results puts radiologists in a bind

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

How to make Best Hospitals ratings actually useful for patients

Departing Stanford president retracts two papers

focus

hotspot

hotspot

hotspot